Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Rogers

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Pharmaceutical Research|October 20, 2011
Characterization of recombinant human IL-15 deamidation and its practical elimination through substitution of asparagine 77David F Nellis, Dennis F Michiel, Man-Shiow Jiang, et al.
Frontiers in Pharmacology|July 29, 2024
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal modelsUwe Grether, Richard H Foxton, Sabine Gruener, et al.
Health Technology Assessment (Winchester, England)|August 3, 2019
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCTMatthew Scarborough, Ho Kwong Li, Ines Rombach, et al.
The New England Journal of Medicine|January 31, 2019
Oral versus Intravenous Antibiotics for Bone and Joint InfectionHo-Kwong Li, Ines Rombach, Rhea Zambellas, et al.
American Journal of Human Genetics|November 14, 2007
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studiesAntonis C Antoniou, Olga M Sinilnikova, Jacques Simard, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Pharmaceutical Research|October 20, 2011
Characterization of recombinant human IL-15 deamidation and its practical elimination through substitution of asparagine 77David F Nellis, Dennis F Michiel, Man-Shiow Jiang, et al.
Frontiers in Pharmacology|July 29, 2024
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal modelsUwe Grether, Richard H Foxton, Sabine Gruener, et al.
Health Technology Assessment (Winchester, England)|August 3, 2019
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCTMatthew Scarborough, Ho Kwong Li, Ines Rombach, et al.
The New England Journal of Medicine|January 31, 2019
Oral versus Intravenous Antibiotics for Bone and Joint InfectionHo-Kwong Li, Ines Rombach, Rhea Zambellas, et al.
American Journal of Human Genetics|November 14, 2007
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studiesAntonis C Antoniou, Olga M Sinilnikova, Jacques Simard, et al.
Pageof 8